Effect of bevacizumab in the RFP-tagged osteosarcoma nude mice model of human osteosarcoma in vivo

Meng LU,Sujia WU,Xin SHI,Guangxin ZHOU,Chengjun LI,Jianning ZHAO

2014-01-01

Chinese Clinical Oncology

Abstract:Objective To explore the influence of bevacizumab ( Avastin) on the growth and angiogenesis of RFP-tagged os-teosarcoma orthotopic nude mice model of human osteosarcoma. Methods Twenty-one nude mice inoculated with human osteosarcoma cell line 143-B-RFP were randomly divided into three groups:control group, low dose Avastin group ( Avastin-L) and high dose Avas-tin group ( Avastin-H) . Avastin-L group and Avastin-H group received continuous 0. 2ml injection of 2. 0mg/kg or 5. 0mg/kg Avastin twice a week for 3 weeks, while control group was given an equal volume of saline. The body weight was recorded every 3 days. The in situ tumor size was measured to calculate the volume and the tumor inhibition rate every 7 days by fluorescence imaging system. Immu-nohistochemical En Vision method was used to detect the expression of CD34 in tumor tissue to evaluate the microvessel density ( MVD) . The vascular endothelial growth factor ( VEGF) levels of plasma and tumor tissue were measured by ELISA method. Results No significant difference was observed on body weight and lung metastasis rate among 3 groups ( P>0. 05) . Compared with control group, there were higher tumor inhibition rate, and lower tumor volume, MVD and VEGF levels of plasma and tumor tissue in both Avastin-L group and Avastin-H group (P<0. 05).The improvement effect of the above indexes were stronger in Avastin-H group versus Avastin-L group ( P<0. 05) . Conclusion Avastin can inhibit the growth and angiogenesis of human osteosarcoma, and reduce the VEGF level without influences on lung metastasis.